The argon fluoride excimer laser emits radiation in the far ultraviolet part of the electromagnetic spectrum (193 nm 
The potential of excimer lasers in ophthalmic surgery was first suggested in 1983' following their successful industrial application in etching highly precise patterns into plastics.' A distinct advantage of argon fluoride excimer laser radiation (193 nm) is that there is no significant damage beyond exposed areas. Ultrastructural examination of corneal excisions in animal models confirmed that these could be produced with a very high degree of accuracy and control. Damage to adjacent unexposed tissue was limited to 300 nm beyond the boundary of the zone of ablationi--9 In non-perforating excisions of varying depths endothelial damage was noted only when the base of the excision was within 40 iim of Descemet's membrane, which is similar to but less extensive than diamond knife incisions. 8 'I Furthermore, excisions can be controlled precisely, in terms of uniformity along the length ofa single cut, reproducibility between cuts, and in anticipated cut depth (accuracy ± 3%, diamond knife incisions ± 12%). The first clinical application was therefore the correction of astigmatism with T-cut excisions. 12 The nature of corneal damage induced by excimer radiation at 193 rum is unique, because it results from an extremely high photon energy and high peak power. At this wavelength each photon has an energy of 6-4 electron volts, and, as this exceeds the binding voltage of carboncarbon bonds, a single absorbed photon may lead to bond breakdown.'3 Ultraviolet radiation in this spectral domain does not propagate well in air, and at any biological interface the photons are virtually all absorbed within a few microns of the surface. Thus, with each laser pulse a layer of tissue only a few molecules thick will be ablated from the surface. Tissue damage induced by other clinical lasers is achieved by concentrating laser energy into a focused point. However, the excimer laser beam has a large cross sectional area, and since every photon in the beam has the potential to produce tissue change the entire cross section can be utilised. The 1 cm by 2 cm rectangular profile is adjusted by cylindrical quartz lenses, and the resultant square beam profile becomes circular by passing the emergent beam through an aperture.9 This facility to photoablate large areas of cornea permits selective removal of tissue to induce a refractive change (photorefractive keratectomy -PRK).9 I'l8
For PRK and superficial keratectomy to become accepted in clinical practice an understanding of the nature and quality of wound healing is essential. Complete epithelial wound healing is necessary to re-establish the outer osmotic barrier of the cornea and optical brilliance. Studies have been undertaken to assess latency of wound healing, epithelial migration and adhesion properties, and the presence or absence of hyperplasia. 9 Stromal wound healing has been examined in relation to loss or disturbance of transparency, keratocyte infiltration, and scar formation.'4"620 Endothelium has been assessed in relation to potential cell loss or longterm population changes. 19 21 Finally the putative mutagenic effects of ultraviolet radiation on the cornea have been assessed by both unscheduled DNA repair and tissue culture, coupled with enzyme poisoning techniques.22 23 None of these studies has highlighted areas of concern that would preclude the beginning of clinical trials with the excimer laser at 193 nm (Sliney D, personal communication).
In February 1988, on the basis of laboratory data, ethical committee approval was given to treat overt corneal lesions with the excimer laser. The aim of this study was to determine whether the laser could be used for wide area ablations to remove opacities and produce an optically smooth surface. Since photoablation occurs across the entire area exposed, with repeated pulses the original surface contour will be reproduced in the base of the ablated disc. It was necessary therefore to devise a means of smooth-ing an uneven surface. The (1) The aim of this experiment was to create an irregular surface in cadaver corneas and then to determine whether the excimer laser could smooth these irregular surfaces. Donor eyes were used within 16 hours of death and secured in a Tudor Thomas stand. Ocular rigidity was maintained by injecting normal saline into the vitreous through the pars plana. After removal of the epithelium with a hockey end blade the globe was placed directly beneath the laser aperture and the helium-neon aiming beams focused on the centre of the cornea. An area of stroma was masked by placing a piece of bent wire on the corneal surface in the path of the beam. Fifty pulses of laser energy were then directed on to the partially occluded corneal surface with a 3 mm diameter beam. This resulted in excavation of the stromal surface in areas not shielded by the wire. In areas beneath the wire, ridges of original tissue remained.
The next objective was to remove the induced pattern with the laser to restore a smooth surface across the entire ablated zone. The wire was removed and the excavated areas 'masked' with 1% or 2% hydroxypropylmethylcellulose (HPMC) or polyvinyl alcohol to prevent their further ablation. These tear substitutes have a high water content and were assumed to have similar ablation rates to corneal stroma. (2) In this experiment the excimer laser was used to create a cylindrical excavation 1 mm in diameter and 100 [tm deep. The beam diameter was then increased to 3 mm, the ablated cylinder filled with 1% HPMC, and the surrounding stromal surface carefully dried. Ablation of the stroma was continued until the surrounding stroma had been ablated to the same depth as the original cylinder. In practice this process was monitored by changes in tissue fluorescence to be described in the results.
EXCIMER LASER SMOOTHING OF SURGICAL LAMELLAR KERATECTOMY BEDS
This experiment was designed to assess the potential of the excimer laser in combination with masking agents to smooth irregular corneal surfaces. A series of surgical lamellar keratectomies was performed on donor eyes. The initial incision was made with a disposable 6 mm trephine, and the lamellar dissection was done with a steel blade and Paufique's knives, beginning at the base of the trephine cut. HPMC was applied to the keratectomy base and its amount and distribution adjusted, while multiple overlapping ablation zones were produced until the base was smooth.
HISTOPATHOLOGY
After laser exposure a 5 mm penetrating incision into the posterior globe was made and the eyes were immersed in fixative. The initial fixative used was 2 5% glutaraldehyde buffered in 1 M sodium cacodylate with 10 g/l calcium chloride at a final pH of . After 24 hours the corneas were prepared for light microscopy (LM) and electron microscopy (EM). Those (Fig 3B) . Multiple overlapping ablation zones were used to smooth the entire keratectomy base (Fig 3C) . Zones already smoothed were masked with HPMC to avoid unnecessary ablation. This (Fig 4A) . The right eye was normal. In February 1988 she became the first sighted patient to undergo excimer laser superficial keratectomy (ELSK). She had multiple overlapping zones located in the central 6 mm of the cornea (Fig 4B) . Approximately 300-400 pulses were delivered to each site of ablation. The procedure was pain-free. One hour later, however, she complained of some discomfort, which resolved over 36 hours when the cornea had reepithelialised. One week later she was asymptomatic. At this stage the area of photoablation was smooth, with minimal central thinning and a faint anterior stromal haze. The acuity was 6/24 improving to 6/12 with pinhole. At five months there was early recurrence of band keratopathy (Fig 4C) . By 18 months it began to cause Figure 5B discomfort. A small central epithelial erosion and faint central stromal haze were noted at this time, with the zone of ablation remaining markedly clearer than the surrounding area (Fig 4D) . sarcoidosis and bilateral panuveitis, the left eye being worse than the right. Acuities were 6/6 right, hand movement left. There was a fine, even band keratopathy across the lower two thirds of the left cornea with early peripheral changes in the right eye. (Fig 6A) . The surface quality postoperatively was best demonstrated by photokeratoscopy (Figs 6B, C) .
Case 4
A 72-year-old male had bilateral idiopathic evenly distributed band keratopathy (Fig 7A) . He had no discomfort but complained of glare and impaired vision: 6/24 right and 6/18 left. He had a right 4 mm axial ELSK without HPMC and the appearance at three months is seen in Figs 7B and 7C. Fig 7C, using sclerotic scatter, highlights the clarity of the central cornea compared to the adjacent band keratopathy against the background of the dilated pupil. Visual acuity in the right eye improved to 6/12, but veiling glare was subjectively unchanged.
Case S A 32-year-old Jamaican female had been blind in the right eye (no perception of light) from childhood. The cause was unknown. The eye was very uncomfortable. The left eye was normal.
There was a moderately dense band keratopathy across the inferior two thirds of the right cornea and discrete white deep stromal deposits in the same area (Fig 8A) . There was seclusio pupillae and a dense cataract. ELSK was carried out with five 3 mm diameter partially overlapping zones (Fig 8B) . Within 48 hours she was asymptomatic with an intact epithelium.
One year after treatment she had occasional mild photophobia. There was a faint anterior stromal haze in areas of ablation, with evidence of recurrence of band keratopathy in the centre of these zones, with a further peripheral deposition causing irregular boundaries (Fig 8C) . WI~.; A 67-year-old male developed a dense evenly distributed band keratopathy in his right eye after retinal detachment surgery which had included injection of silicone oil (Fig 9A) . He had also undergone extracapsular cataract extraction with insertion ofa posterior chamber intraocular lens. Before photoablation there was only a limited view into the anterior chamber in which silicone oil was present. Vision was hand movements in the inferior field only. ELSK was undertaken for cosmetic reasons and to improve the view of the posterior segment.
Overlapping ablation zones were used to clear the cornea of band. 1% HPMC was used to mask previously ablated areas. At three months the cornea was clear, with an optically smooth surface (Fig 9B) . A good view of the anterior chamber, intraocular lens and retina was obtained. As expected, there was no significant improvement in vision.
GENERAL COMMENTS
No patients reported discomfort during the procedure. Postoperatively most of them experienced some discomfort for hours. The intensity and duration of discomfort was related to the area of ablation. All patients required oral analgesics for 24 hours. In all cases re-epithelialisation was complete by 48 hours.
Sixteen of the 25 patients had an improvement in visual acuity (Tables 1-5 ). The 13 patients with uneven, symptomatic (painful) corneal surface became symptom free.
Improvement in visual acuity occurred in those patients who had an even band keratopathy which responded well to photoablation with minimal or no masking. In the seven patients troubled by glare (typically eyes with good visual potential and an evenly distributed 'ground glass' band keratopathy) all were markedly improved postoperatively. Three patients in the series were pleased with the improved appearance of their eyes.
In most of the cases treated it was impossible to assess the central endothelium preoperatively owing to the overlying band keratopathy. Examination by slit-lamp specular microscopy was carried out postoperatively at various stages of the follow-up, and none of the patients was found to have any endothelial disturbance.
Discussion
Our studies have not identified any coniplications or undesirable findings that would preclude further investigation of the clinical use of excimer lasers in ophthalmic practice.
Excimer laser ablation is a surface phenomenon and therefore irregular surfaces cannot be levelled as a single stage procedure by irradiation. If a rough surface of homogeneous tissue is irradiated, a uniform layer of tissue will be removed with each laser pulse (Fig 10) , and in order to produce a smooth surface a masking agent with a similar ablation rate to that of the target material must be used (Fig 11) where surface projections are formed by inclusions, such as calcium, with a lower ablation rate than that of intervening tissue troughs (Fig 12) . Surface smoothing in this case requires an adjustable 'shield' through which the calcium peaks protrude and are ablated while the troughs are protected. The shield may then be lowered to complete the smoothing process. An ablation fluid with a slow ablation rate would be prefer- Tables I to 5 show that postoperative progress was related to the extent of the initial pathology. Systematic analysis of the patient subsets was difficult, because there were significant variations in pathology. However, all patients with rough band keratopathy who had experienced pain preoperatively became asymptomatic (Tables 1  and 2 ). Most were treated with several overlapping ablation zones in order to smooth the cornea completely (Tables 1 and 2 ). (Table 3) .
Smooth surfaced band deposition was treated with either several overlapping ablation zones (Table 4) or a single 'on-axis' ablation 4 mm in diameter (Table 5 ). The principal symptoms were reduced visual acuity and glare. Those patients with glare had a marked improvement which was sustained throughout the follow-up period (6 months to 2½12 years). In the group treated with overlapping zones one patient showed an increase in visual acuity, one a reduced visual acuity, and the other three no significant difference. Where refraction results could be obtained, a 'plus shift' -that is, towards hypermetropia -was noted (cases 18 and 19, Table 6 ). In case 19 glare was markedly improved but acuity decreased. This reduction was due to irregular astigmatism because of the facetted surface generated by overlapping ablation zones. In contrast, in the group in which a central 'on-axis' zone was ablated (Table 5) visual acuity was improved in each case and glare reduced. In three of these cases a hyperopic shift was noted. In those patients in whom measurements were possible the mean hyperopic shift was 2-85 dioptres (Table 6) .
From this study, which is the first reported series of corneal disease treated with an excimer laser, it is possible to put forward recommendations for selection of patients. First, for patients with rough band keratopathy the excimer laser provides successful treatment. All patients with pain and photophobia became asymptomatic (in general these eyes will have limited visual potential owing to the underlying pathology). Secondly, where the pathology is limited to the Thirdly, the centrifugal spray of particles of debris and ablation products might be expected to shield the stroma and would theoretically provide progressively greater shielding towards the edge of the ablated zone. Fourthly, the increased obliquity of incident radiation falling on more peripheral cornea might result in a relative decrease in energy density as the edge of the ablation zone is approached. It is unlikely, however, that the degree of differential ablation encountered could arise from inhomogeneities in the excimer beam.
In conclusion, given the encouraging results, the ease with which the procedure can be performed, the patient acceptance of the procedure, and the fact that we have treated all cases on an outpatient basis, we consider excimer ablation the treatment of choice for these cases.
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